Transcept Pharmaceuticals, Inc.
Pharmaceutical ManufacturingUnited States11-50 Employees
A specialty pharmaceutical company acquired by Paratek Pharmaceuticals (Nasdaq:PRTK) on October 30, 2014..
Specialized Market Niche Transcept Pharmaceuticals operates within the niche of specialty pharmaceutical manufacturing, suggesting opportunities to offer customized solutions or partnerships tailored to niche drug development, manufacturing efficiency, or regulatory support.
Financial Growth Potential With revenues between 1 million and 10 million dollars, the company is a smaller player with growth potential; engaging with innovative service providers or technology solutions could support their expansion and market reach.
Technology Stack Utilization Utilizing tools like Google Analytics and Nginx indicates a focus on digital engagement and web infrastructure, opening opportunities for digital marketing services or cybersecurity solutions to enhance their online presence.
Acquisition & Expansion Being acquired by Paratek Pharmaceuticals since 2014 suggests an openness to strategic partnerships and integrating new technologies or clinical research collaborations to accelerate development pipelines.
Industry and Competitive Context Operating alongside larger firms like Jazz Pharmaceuticals and Purdue Pharma, Transcept can benefit from targeted solutions in regulatory compliance, market analysis, and specialty pharmaceutical supply chain management to strengthen their market position.
Transcept Pharmaceuticals, Inc. uses 5 technology products and services including Google Fonts API, jQuery, Google Analytics, and more. Explore Transcept Pharmaceuticals, Inc.'s tech stack below.
| Transcept Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@transcept.com | 44% |
| First@transcept.com | 6% |
| Last@transcept.com | 6% |
| FLast@transcept.com | 44% |
Pharmaceutical ManufacturingUnited States11-50 Employees
A specialty pharmaceutical company acquired by Paratek Pharmaceuticals (Nasdaq:PRTK) on October 30, 2014..
Transcept Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M
Transcept Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M